Here’s When The Old Guard 2 Is Dropping — And Why It’ll Be Bigger Than the First
After the unexpected success of The Old Guard in 2020, fans have been eagerly awaiting the return of their favorite immortal warriors. Now, the anticipation is building once again with the announcement of The Old Guard 2. From updates on the The Old Guard 2 release date to exciting new cast additions, this sequel promises more thrilling action, deeper mythology, and epic battles.
Here’s everything you need to know about The Old Guard 2, including the trailer, the cast of The Old Guard 2, and what fans can expect from the plot.
The Old Guard 2 Release Date: When Is It Coming?
One of the most asked questions right now is: When is The Old Guard 2 coming out?
As of mid-2025, The Old Guard 2 release date has not been officially confirmed by Netflix. However, reports indicate the movie has completed filming and is currently in post-production. Based on production timelines and release strategies, a late 2025 release—possibly in Q4—is highly likely.
Stay tuned to Netflix’s official announcements for the exact The Old Guard 2 release date.
The Old Guard 2 Trailer: First Look at the Sequel
While fans are still waiting for a full-length The Old Guard 2 trailer, Netflix has teased brief behind-the-scenes footage and concept art, building anticipation. A teaser or official trailer is expected to drop a few months before the film’s release—most likely in the fall of 2025.
Based on early looks, the trailer is expected to showcase:
-
More globe-trotting action sequences
-
Powerful flashbacks revealing the team’s past lives
-
Tension between old alliances and new enemies
Once the The Old Guard 2 trailer drops, fans can expect explosive visuals, a gripping soundtrack, and the same stylish direction that made the first film so compelling.
Cast of The Old Guard 2: Who's Returning and Who's New?
Returning Cast Members
The cast of The Old Guard 2 sees the return of major players who made the original film so iconic:
-
Charlize Theron as Andy (Andromache of Scythia) – the ancient warrior and team leader
-
KiKi Layne as Nile Freeman – the newest immortal with strong moral resolve
-
Matthias Schoenaerts as
Booker – the conflicted team member seeking redemption -
Marwan Kenzari and Luca Marinelli as Joe and Nicky – a loving couple with unmatched combat skills
-
Chiwetel Ejiofor as Copley – former CIA agent turned ally
New Faces
The sequel introduces new characters that add fresh intrigue to the story. Notably:
-
Uma Thurman – rumored to play a powerful immortal with ties to Andy’s ancient past
-
Henry Golding – cast in a mysterious role that could shift the balance of power
The new additions to the cast of The Old Guard 2 are sure to add depth, tension, and possibly betrayal.
Plot Expectations: What Will The Old Guard 2 Be About?
While Netflix has kept specific plot details under wraps, we can speculate based on the events of the first movie.
At the end of The Old Guard, Booker was exiled from the group and later confronted by Quynh, Andy’s long-lost immortal companion who was believed to have drowned centuries ago. Her return sets the stage for The Old Guard 2 to dive into:
-
Quynh’s emotional and possibly vengeful return
-
Andy grappling with her now-mortal status
-
The ethical dilemmas of immortality
-
Possible flashbacks revealing Quynh’s past
-
Global threats that test the team’s loyalty and strength
With themes of trust, betrayal, and the burden of endless life, The Old Guard 2 promises a richer, darker storyline than its predecessor.
Behind the Scenes: Production Updates and Direction
Victoria Mahoney steps in as the director of The Old Guard 2, making history as the first woman of color to direct a major comic-book movie adaptation. Her creative vision brings a fresh, dynamic perspective to the franchise.
Production wrapped in early 2024 after filming across multiple international locations, including the UK and Italy. Expect the same sleek fight choreography, stylized action, and emotionally resonant storytelling that made the original film a standout.
Why Fans Are Excited
There are several reasons why The Old Guard 2 is one of the most anticipated Netflix films of the year:
-
Strong character development, especially among the immortals
-
A focus on morally complex storytelling
-
Visually stunning action scenes
-
Representation of LGBTQ+ relationships in mainstream action films
-
A unique take on the superhero genre without spandex or capes
Whether you loved the emotional arc of Nile or the centuries-long romance between Joe and Nicky,
Prepare for the Return of the Immortals
With its global fanbase, powerful cast, and emotional storytelling, The Old Guard 2 is gearing up to be a game-changer in the world of action sequels. While we wait for an official The Old Guard 2 release date and the much-anticipated trailer, fans can rest assured that this sequel is worth the wait.
From Charlize Theron’s fierce portrayal of Andy to the mysterious arrival of Quynh, this next chapter promises more than just immortal sword fights—it offers heart, history, and high stakes.
Dad with deadly brain cancer that kills in a year is cancer free after taking new drug
A breakthrough drug is fighting brain cancer head-on.
Glioblastoma is widely considered the deadliest form of brain cancer, killing over 10,000 Americans each year. There is no cure for the highly aggressive disease — many patients survive just nine months after diagnosis.
Ben Trotman was diagnosed with glioblastoma in October 2022 at 40.
Treatment focuses on managing symptoms and extending life via surgery to remove as much of the tumor as possible and radiation therapy and chemotherapy to destroy cancer cells.
Now, researchers from University College London Hospitals are recruiting glioblastoma patients for a trial of the immunotherapy drug ipilimumab. Sold under the brand name Yervoy, the monoclonal antibody stimulates the immune system to recognize and attack cancer cells.
Oncologists are optimistic since a UK father shows no signs of having a tumor after he took ipilimumab before his glioblastoma treatment.
Ben Trotman was diagnosed with glioblastoma in October 2022 at 40.
“The crucial element of this trial is that patients will have their immune system boosted by the drug before they have any other treatment, when they are fit and well enough to tolerate the immunotherapy,” said Dr. Paul Mulholland, the consultant medical oncologist leading the trial.
“We saw with Ben, the one patient recruited to the immunotherapy study, NeAT-GLIO, that he has had clear scans since having the treatment and the tumor hasn’t returned more than two and a half years later.”
Glioblastoma is widely considered the deadliest form of brain cancer, killing over 10,000 Americans each year.
Trotman met with Mulholland, who enrolled him in a clinical trial for ipilimumab. He was the first patient in the world — and the only person in the trial — to take the drug before glioblastoma treatment.
“Getting this diagnosis was the most traumatic experience,” said Trotman’s wife, Emily.
“We were grappling with the fact that Ben had gone from being apparently perfectly healthy to having months to live.”
After taking the drug, Ben underwent radiotherapy and chemotherapy.
Two years and eight months later, his scans are clear.
“It is very unusual to have a clear scan with glioblastoma, especially when he didn’t have the follow-up surgery that had been planned to remove all of the tumor that was initially visible on scans,” Mulholland said.
Ben and Emily Trotman wed in 2023, after he began his immunotherapy treatment.
“We hope that the immunotherapy and follow-up treatment Ben has had will hold his tumor at bay,” he added, “and it has so far, which we are delighted to see.”
In January 2023, months after his diagnosis, Ben married Emily. The couple welcomed a daughter, Mabel, earlier this year.
They enjoy taking her for walks along with their rescue dog, Jerry.
“We are trying to live as normal a life as possible,” Emily said.
“We are in a unique position of which there is no precedent and which comes with a great deal of uncertainty,” she continued. “We want to live each day as if it were our last, but we also want to plan for the future, which we hope to have.”
Researchers plan to recruit 16 glioblastoma patients like Ben over 18 months.
After taking ipilimumab, the trial participants will undergo radiotherapy and chemotherapy and perhaps surgery depending on the extent of their disease.
Dr. Paul Mulholland and Dame Siobhain McDonagh, who raised funds for the new clinical trial of ipilimumab.
The trial is being funded by Dame Siobhain McDonagh, a member of the British Parliament, whose sister died of glioblastoma in 2023.
“My beloved sister Margaret was appalled to discover that there had been no advances in brain cancer treatment for decades when she was diagnosed with glioblastoma,” McDonagh said. “Changing this was Margaret’s final campaign and one that I have continued in her memory.”
Treatment will take place at the NIHR UCLH’s Clinical Research Facility at the National Hospital for Neurology and Neurosurgery.
“I am delighted that this new trial, with the same immunotherapy drug I received, is going ahead and others will have the opportunity to take part,” Ben said. “It will give people newly diagnosed with glioblastoma some hope.”